{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T01:40:56Z","timestamp":1776217256711,"version":"3.50.1"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["TMA2019SFP-2843"],"award-info":[{"award-number":["TMA2019SFP-2843"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-050873"],"award-info":[{"award-number":["INV-050873"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"World Bank African Centres of Excellence"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>While artemisinin-based combination therapies (ACTs) are effective in sub-Saharan Africa, clinical isolates that are refractory to artemisinin derivatives are emerging in East Africa and ACT partner drugs are becoming less effective in West Africa. We investigated the ex vivo responses of Plasmodium falciparum clinical isolates to frontline antimalarials and the contribution of validated molecular markers of antimalarial drug resistance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Ex vivo susceptibility was measured for 66 clinical isolates collected from uncomplicated malaria patients. IC50 was measured for dihydroartemisinin, artesunate, lumefantrine, amodiaquine and chloroquine using a SYBR Green I growth inhibition assay. We also assessed known drug resistance-mediating polymorphisms in pfcrt, pfmdr1 and pfkelch13 using Oxford Nanopore amplicon sequencing.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>P. falciparum clinical isolates were susceptible to dihydroartemisinin and artesunate. Clinical isolates showed a wide distribution of susceptibility to lumefantrine and amodiaquine, with some parasites having IC50 values above reference cut-offs for resistance to lumefantrine (150\u2005nM) and amodiaquine (60\u2005nM), suggesting decreased drug susceptibility. Ninety-seven percent of the isolates carried WT pfcrt K76 and pfmdr1 N86 alleles, reported to mediate reduced response to lumefantrine and artemether\/lumefantrine. pfmdr1 N86 and 184F haplotype was carried by 62.1% of parasites. None of the clinical isolates carried validated pfkelch13 mutations known to mediate artemisinin partial resistance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Clinical isolates from coastal Ghana remain susceptible to artemisinin derivatives in commonly used ACTs in Ghana. However, we observed lower susceptibility to the ACT partner drugs lumefantrine and amodiaquine, suggesting the emergence of drug-tolerance phenotypes. Consistent surveillance of drug phenotype\u2013genotype is needed to support ACT efficacy in Ghana.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkaf129","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T15:48:43Z","timestamp":1746805723000},"page":"1813-1822","source":"Crossref","is-referenced-by-count":3,"title":["<i>Plasmodium falciparum<\/i> isolates: <i>ex vivo<\/i> drug response"],"prefix":"10.1093","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4655-9515","authenticated-orcid":false,"given":"Edem","family":"Adika","sequence":"first","affiliation":[{"name":"West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra ,","place":["Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samirah","family":"Saiid","sequence":"additional","affiliation":[{"name":"West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra ,","place":["Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enock K","family":"Amoako","sequence":"additional","affiliation":[{"name":"West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra ,","place":["Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona-Liza E","family":"Sakyi","sequence":"additional","affiliation":[{"name":"West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra ,","place":["Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Osumanu","sequence":"additional","affiliation":[{"name":"West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra ,","place":["Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Collins","family":"Morang\u2019a","sequence":"additional","affiliation":[{"name":"West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra ,","place":["Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Dosoo","sequence":"additional","affiliation":[{"name":"West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra ,","place":["Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jersley D","family":"Chirawurah","sequence":"additional","affiliation":[{"name":"West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra ,","place":["Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon A","family":"Awandare","sequence":"additional","affiliation":[{"name":"West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra ,","place":["Ghana"]},{"name":"Department of Biochemistry, Cell and Molecular Biology (BCMB), University of Ghana, Accra ,","place":["Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4478-3601","authenticated-orcid":false,"given":"Alfred","family":"Amambua-Ngwa","sequence":"additional","affiliation":[{"name":"Medical Research Council Unit, The Gambia at LSHTM , Banjul ,","place":["The Gambia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaw","family":"Aniweh","sequence":"additional","affiliation":[{"name":"West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra ,","place":["Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas N","family":"Amenga-Etego","sequence":"additional","affiliation":[{"name":"West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Accra ,","place":["Ghana"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"2025070104564577500_dkaf129-B1","volume-title":"World Malaria Report 2022","author":"WHO","year":"2023"},{"key":"2025070104564577500_dkaf129-B2","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/bfgp\/elz008","article-title":"The genomic architecture of antimalarial drug resistance","volume":"18","author":"Cowell","year":"2019","journal-title":"Brief Funct Genomics"},{"key":"2025070104564577500_dkaf129-B3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1473-3099(18)30068-9","article-title":"Origins of the current outbreak of multidrug-resistant malaria in Southeast Asia: a retrospective genetic study","volume":"18","author":"Amato","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2025070104564577500_dkaf129-B4","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ng.2624","article-title":"Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia","volume":"45","author":"Miotto","year":"2013","journal-title":"Nat Genet"},{"key":"2025070104564577500_dkaf129-B5","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMc0805011","article-title":"Evidence of artemisinin-resistant malaria in western Cambodia","volume":"359","author":"Noedl","year":"2008","journal-title":"N Engl J Med"},{"key":"2025070104564577500_dkaf129-B6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","article-title":"The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study","volume":"17","author":"Imwong","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2025070104564577500_dkaf129-B7","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","article-title":"Evidence of artemisinin-resistant malaria in Africa","volume":"385","author":"Balikagala","year":"2021","journal-title":"N Engl J Med"},{"key":"2025070104564577500_dkaf129-B8","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3201\/eid2404.170141","article-title":"Artemisinin-resistant Plasmodium falciparum with high survival rates, Uganda, 2014\u20132016","volume":"24","author":"Ikeda","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2025070104564577500_dkaf129-B9","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat Med"},{"key":"2025070104564577500_dkaf129-B10","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/s41564-023-01461-4","article-title":"Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia","volume":"8","author":"Fola","year":"2023","journal-title":"Nat Microbiol"},{"key":"2025070104564577500_dkaf129-B11","doi-asserted-by":"publisher","first-page":"e00759-17","DOI":"10.1128\/AAC.00759-17","article-title":"Sustained ex vivo susceptibility of Plasmodium falciparum to artemisinin derivatives but increasing tolerance to artemisinin combination therapy partner quinolines in the Gambia","volume":"61","author":"Amambua-Ngwa","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2025070104564577500_dkaf129-B12","doi-asserted-by":"publisher","first-page":"e00720-20","DOI":"10.1128\/AAC.00720-20","article-title":"Tolerance of Gambian Plasmodium falciparum to dihydroartemisinin and lumefantrine detected by ex vivo parasite survival rate assay","volume":"65","author":"Mbye","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2025070104564577500_dkaf129-B13","doi-asserted-by":"publisher","first-page":"105828","DOI":"10.1016\/j.actatropica.2021.105828","article-title":"Current methods for the detection of antimalarial drug resistance in Plasmodium parasites infecting humans","volume":"216","author":"Slater","year":"2021","journal-title":"Acta Trop"},{"key":"2025070104564577500_dkaf129-B14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/2229-5070.175081","article-title":"Antimalarial drug resistance: an overview","volume":"6","author":"Antony","year":"2016","journal-title":"Trop Parasitol"},{"key":"2025070104564577500_dkaf129-B15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.actatropica.2005.06.018","article-title":"Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana","volume":"95","author":"Koram","year":"2005","journal-title":"Acta Trop"},{"key":"2025070104564577500_dkaf129-B16","doi-asserted-by":"publisher","first-page":"1058660","DOI":"10.3389\/fcimb.2022.1058660","article-title":"Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana","volume":"12","author":"Abuaku","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"2025070104564577500_dkaf129-B17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/s12936-021-03974-x","article-title":"Evaluation of pilot implementation of seasonal malaria chemoprevention on morbidity in young children in Northern Sahelian Ghana","volume":"20","author":"Ansah","year":"2021","journal-title":"Malar J"},{"key":"2025070104564577500_dkaf129-B18","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1038\/s41564-023-01516-6","article-title":"Drug resistance and vaccine target surveillance of Plasmodium falciparum using nanopore sequencing in Ghana","volume":"8","author":"Girgis","year":"2023","journal-title":"Nat Microbiol"},{"key":"2025070104564577500_dkaf129-B19","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","article-title":"Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening","volume":"48","author":"Smilkstein","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2025070104564577500_dkaf129-B20","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/molbev\/msaa015","article-title":"IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era","volume":"37","author":"Minh","year":"2020","journal-title":"Mol Biol Evol"},{"key":"2025070104564577500_dkaf129-B21","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/1475-2875-10-268","article-title":"Reduced in vitro susceptibility to artemisinin derivatives associated with multi-resistance in a traveller returning from South-East Asia","volume":"10","author":"Pradines","year":"2011","journal-title":"Malar J"},{"key":"2025070104564577500_dkaf129-B22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1475-2875-12-107","article-title":"Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study","volume":"12","author":"Fall","year":"2013","journal-title":"Malar J"},{"key":"2025070104564577500_dkaf129-B23","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1475-2875-12-450","article-title":"A SYBR green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs","volume":"12","author":"Quashie","year":"2013","journal-title":"Malar J"},{"key":"2025070104564577500_dkaf129-B24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1179\/136485907X176553","article-title":"The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs","volume":"101","author":"Quashie","year":"2007","journal-title":"Ann Trop Med Parasitol"},{"key":"2025070104564577500_dkaf129-B25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1056\/NEJMp1403340","article-title":"The origins of antimalarial-drug resistance","volume":"371","author":"Packard","year":"2014","journal-title":"N Engl J Med"},{"key":"2025070104564577500_dkaf129-B26","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S1473-3099(12)70181-0","article-title":"Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study","volume":"12","author":"Amaratunga","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"2025070104564577500_dkaf129-B27","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1056\/NEJMoa2210956","article-title":"Increasing prevalence of artemisinin-resistant HRP2-negative malaria in Eritrea","volume":"389","author":"Mihreteab","year":"2023","journal-title":"N Engl J Med"},{"key":"2025070104564577500_dkaf129-B28","doi-asserted-by":"publisher","author":"Ishengoma","DOI":"10.1101\/2024.01.31.24301954"},{"key":"2025070104564577500_dkaf129-B29","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.1038\/s41467-022-33873-x","article-title":"Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda","volume":"13","author":"Tumwebaze","year":"2022","journal-title":"Nat Commun"},{"key":"2025070104564577500_dkaf129-B30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12936-021-03585-6","article-title":"Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017\u20132018","volume":"20","author":"Gansan\u00e9","year":"2021","journal-title":"Malar J"},{"key":"2025070104564577500_dkaf129-B31","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1128\/AAC.03647-14","article-title":"In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso","volume":"59","author":"Baraka","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2025070104564577500_dkaf129-B32","doi-asserted-by":"publisher","first-page":"e0151565","DOI":"10.1371\/journal.pone.0151565","article-title":"Artesunate-amodiaquine and artemether-lumefantrine therapies and selection of Pfcrt and Pfmdr1 alleles in Nanoro, Burkina Faso","volume":"11","author":"Sondo","year":"2016","journal-title":"PLoS One"},{"key":"2025070104564577500_dkaf129-B33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1365-3156.2004.01382.x","article-title":"A randomized comparative study of chloroquine, amodiaquine and sulphadoxine\u2013pyrimethamine for the treatment of uncomplicated malaria in Ghana","volume":"10","author":"Oduro","year":"2005","journal-title":"Trop Med Int Health"},{"key":"2025070104564577500_dkaf129-B34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12936-019-2848-1","article-title":"Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations for uncomplicated malaria in 10 sentinel sites across Ghana: 2015\u20132017","volume":"18","author":"Abuaku","year":"2019","journal-title":"Malar J"},{"key":"2025070104564577500_dkaf129-B35","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1038\/s41598-020-60549-7","article-title":"Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania","volume":"10","author":"Bwire","year":"2020","journal-title":"Sci Rep"},{"key":"2025070104564577500_dkaf129-B36","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1093\/infdis\/jiu216","article-title":"Return of widespread chloroquine-sensitive Plasmodium falciparum to Malawi","volume":"210","author":"Frosch","year":"2014","journal-title":"J Infect Dis"},{"key":"2025070104564577500_dkaf129-B37","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jiph.2022.03.015","article-title":"Molecular surveillance of chloroquine-resistant Plasmodium falciparum in sub-Saharan African countries after withdrawal of chloroquine for treatment of uncomplicated malaria: a systematic review","volume":"15","author":"Njiro","year":"2022","journal-title":"J Infect Public Health"},{"key":"2025070104564577500_dkaf129-B38","doi-asserted-by":"publisher","first-page":"e00802-19","DOI":"10.1128\/AAC.00802-19","article-title":"Plasmodium falciparum kelch propeller polymorphisms in clinical isolates from Ghana from 2007 to 2016","volume":"63","author":"Matrevi","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2025070104564577500_dkaf129-B39","doi-asserted-by":"publisher","first-page":"7797","DOI":"10.1038\/s41598-022-11790-9","article-title":"Novel pfk13 polymorphisms in Plasmodium falciparum population in Ghana","volume":"12","author":"Matrevi","year":"2022","journal-title":"Sci Rep"},{"key":"2025070104564577500_dkaf129-B40","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s12936-020-03506-z","article-title":"Plasmodium falciparum multidrug resistance gene-1 polymorphisms in Northern Nigeria: implications for the continued use of artemether-lumefantrine in the region","volume":"19","author":"Adamu","year":"2020","journal-title":"Malar J"},{"key":"2025070104564577500_dkaf129-B41","doi-asserted-by":"publisher","first-page":"e31623","DOI":"10.1371\/journal.pone.0031623","article-title":"Genome wide adaptations of Plasmodium falciparum in response to lumefantrine selective drug pressure","volume":"7","author":"Mwai","year":"2012","journal-title":"PLoS One"},{"key":"2025070104564577500_dkaf129-B42","doi-asserted-by":"publisher","first-page":"7032","DOI":"10.1128\/AAC.03494-14","article-title":"Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin","volume":"58","author":"Wurtz","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2025070104564577500_dkaf129-B43","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1016\/S2666-5247(20)30094-X","article-title":"Molecular surveillance of antimalarial partner drug resistance in sub-Saharan Africa: a spatial-temporal evidence mapping study","volume":"1","author":"Ehrlich","year":"2020","journal-title":"Lancet Microbe"},{"key":"2025070104564577500_dkaf129-B44","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1038\/ncomms11553","article-title":"Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies","volume":"7","author":"Veiga","year":"2016","journal-title":"Nat Commun"},{"key":"2025070104564577500_dkaf129-B45","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1128\/AAC.00638-09","article-title":"In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1","volume":"53","author":"Mwai","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2025070104564577500_dkaf129-B46","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.1128\/AAC.02902-14","article-title":"Flow cytometry-based analysis of artemisinin-resistant Plasmodium falciparum in the ring-stage survival assay","volume":"58","author":"Amaratunga","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2025070104564577500_dkaf129-B47","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","article-title":"Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies","volume":"13","author":"Witkowski","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"2025070104564577500_dkaf129-B48","doi-asserted-by":"publisher","first-page":"868723","DOI":"10.3389\/fphar.2022.868723","article-title":"Plasmodium falciparum drug resistance genes pfmdr1 and pfcrt in vivo co-expression during artemether-lumefantrine therapy","volume":"13","author":"Silva","year":"2022","journal-title":"Front Pharmacol"},{"key":"2025070104564577500_dkaf129-B49","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/1475-2875-12-377","article-title":"Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy","volume":"12","author":"Duah","year":"2013","journal-title":"Malar J"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/7\/1813\/63138369\/dkaf129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/7\/1813\/63138369\/dkaf129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:56:52Z","timestamp":1751360212000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/80\/7\/1813\/8127978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,5,9]]},"published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaf129","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,5,9]]}}}